UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 212

Sortiert nach

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

JAMA : the journal of the American Medical Association, 1999-07, Vol.282 (2), p.137

1999

Link zum Volltext

Verfügbarkeit prüfen

Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1

The Journal of infectious diseases, 1996-02, Vol.173 (2), p.340-348

1996

Link zum Volltext

Verfügbarkeit prüfen

A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responses in Seronegative Volunteers

The Journal of infectious diseases, 1999-08, Vol.180 (2), p.290-298

1999

Link zum Volltext

Verfügbarkeit prüfen

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers

AIDS (London), 1998-12, Vol.12 (18), p.2407-2415

1998

Link zum Volltext

Verfügbarkeit prüfen

Safety profile of phase I and II preventive HIV type 1 envelope vaccination : Experience of the NIAID AIDS vaccine evaluation group

AIDS research and human retroviruses, 1997-09, Vol.13 (14), p.1163-1177

1997

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines

The Journal of infectious diseases, 1998-02, Vol.177 (2), p.310-309

1998

Link zum Volltext

Verfügbarkeit prüfen

Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3

AIDS research and human retroviruses, 1998-10, Vol.14 Suppl 3, p.S325-S331

1998

Link zum Volltext

Verfügbarkeit prüfen

Immunization with Envelope MN rgp120 Vaccine in Human Immunodeficiency Virus-Infected Pregnant Women

The Journal of infectious diseases, 1999-10, Vol.180 (4), p.1080-1088

1999

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of a Canarypox-Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher- and Lower-Risk Volunteers

The Journal of infectious diseases, 2001-05, Vol.183 (9), p.1343-1352

2001

Link zum Volltext

Verfügbarkeit prüfen

QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans

Vaccine, 2001-02, Vol.19 (15), p.2080-2091

2001

Link zum Volltext

Verfügbarkeit prüfen

HIV type 1 vaccine-induced T cell memory and cytotoxic T lymphocyte responses in HIV type 1-uninfected volunteers

AIDS research and human retroviruses, 2001-08, Vol.17 (12), p.1175-1189

2001

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors

Vaccine, 2001-09, Vol.19 (32), p.4703-4709

2001

Link zum Volltext

Verfügbarkeit prüfen

Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial

Journal of acquired immune deficiency syndromes (1999), 2004-11, Vol.37 (3), p.1385

2004

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults

Journal of Clinical Microbiology, 1990-11, Vol.28 (11), p.2539-2550

1990

Link zum Volltext

Verfügbarkeit prüfen

Immunity to Influenza in Older Adults with Chronic Obstructive Pulmonary Disease

The Journal of infectious diseases, 2004-07, Vol.190 (1), p.11-19

2004

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Systemic and Mucosal Delivery of 2 Canarypox Virus Vaccines Expressing either HIV-1 Genes or the Gene for Rabies Virus G Protein

The Journal of infectious diseases, 2004-04, Vol.189 (7), p.1221-1231

2004

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A

Journal of acquired immune deficiency syndromes (1999), 2002-03, Vol.29 (3), p.254

2002

Link zum Volltext

Verfügbarkeit prüfen

Influenza Virus Vaccination of Patients With Chronic Lung Disease

Chest, 1997-11, Vol.112 (5), p.1221-1233

1997

Link zum Volltext

Verfügbarkeit prüfen

Recognizing Influenza in Older Patients with Chronic Obstructive Pulmonary Disease Who Have Received Influenza Vaccine

Clinical infectious diseases, 2003-01, Vol.36 (2), p.169-174

2003

Link zum Volltext

Verfügbarkeit prüfen

Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adults

Chest, 1991-10, Vol.100 (4), p.977-984

1991

Link zum Volltext

Verfügbarkeit prüfen

Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategies

Vaccine, 1999-12, Vol.18 (9), p.835-849

1999

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II trials of preventive HIV vaccine candidates. Dose and schedule : summary

AIDS research and human retroviruses, 1994, Vol.10, p.S141-S143

GORSE, G. J

1994

Link zum Volltext

Verfügbarkeit prüfen

MN and IIIB recombinant glycoprotein 120 vaccine-induced binding antibodies to native envelope glycoprotein of human immunodeficiency virus type 1 primary isolates

AIDS research and human retroviruses, 1999-07, Vol.15 (10), p.921-930

1999

Link zum Volltext

Verfügbarkeit prüfen

HIV‐1 recombinant gp160 vaccine given in accelerated dose schedules

Clinical and experimental immunology, 1994-11, Vol.98 (2), p.178-184

1994

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 212

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(178)

Publikationsform

Artikel
(205)
Tagungsberichte
(7)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(114)
Humans
(90)
Life Sciences & Biomedicine
(89)
Biological And Medical Sciences
(59)
Adult
(49)
Infectious Diseases
(49)
Middle Aged
(48)
Male
(45)
Microbiology
(44)
Immunology
(43)
Female
(42)
Aids/hiv
(40)
Medical Sciences
(36)
Virology
(36)
Aids Vaccines - Immunology
(34)
Fundamental And Applied Biological Sciences. Psychology
(34)
Hiv-1 - Immunology
(34)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(29)
Double-Blind Method
(28)
Human Immunodeficiency Virus 1
(28)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1

A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responses in Seronegative Volunteers

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers

Safety profile of phase I and II preventive HIV type 1 envelope vaccination : Experience of the NIAID AIDS vaccine evaluation group

Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines

Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3

Immunization with Envelope MN rgp120 Vaccine in Human Immunodeficiency Virus-Infected Pregnant Women

Safety and Immunogenicity of a Canarypox-Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher- and Lower-Risk Volunteers

QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans

HIV type 1 vaccine-induced T cell memory and cytotoxic T lymphocyte responses in HIV type 1-uninfected volunteers

Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors

Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial

Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults

Immunity to Influenza in Older Adults with Chronic Obstructive Pulmonary Disease

Comparison of Systemic and Mucosal Delivery of 2 Canarypox Virus Vaccines Expressing either HIV-1 Genes or the Gene for Rabies Virus G Protein

Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study

Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A

Influenza Virus Vaccination of Patients With Chronic Lung Disease

Recognizing Influenza in Older Patients with Chronic Obstructive Pulmonary Disease Who Have Received Influenza Vaccine

Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adults

Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategies

Phase I/II trials of preventive HIV vaccine candidates. Dose and schedule : summary

MN and IIIB recombinant glycoprotein 120 vaccine-induced binding antibodies to native envelope glycoprotein of human immunodeficiency virus type 1 primary isolates

HIV‐1 recombinant gp160 vaccine given in accelerated dose schedules

Suchergebnisse filtern